MetLife Investment Management’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.27M | Sell |
11,926
-364
| -3% | -$44.1K | 0.01% | 1399 |
|
|
2026
Q1 | $2.01M | Sell |
12,290
-601
| -5% | -$92.4K | 0.01% | 1057 |
|
|
2025
Q4 | $2.24M | Buy |
12,891
+1,518
| +13% | +$277K | 0.01% | 1027 |
|
|
2025
Q3 | $1.64M | Buy |
11,373
+784
| +7% | +$96K | 0.01% | 1197 |
|
|
2025
Q2 | $1.07M | Sell |
10,589
-89,621
| -89% | -$6.85M | 0.01% | 1273 |
|
|
2025
Q1 | $7.65M | Sell |
100,210
-3,219
| -3% | -$246K | 0.04% | 429 |
|
|
2024
Q4 | $7.14M | Buy |
103,429
+13,807
| +15% | +$994K | 0.04% | 382 |
|
|
2024
Q3 | $6.54M | Buy |
89,622
+52
| +0.1% | +$3.84K | 0.04% | 395 |
|
|
2024
Q2 | $6M | Buy |
89,570
+18,545
| +26% | +$719K | 0.04% | 408 |
|
|
2024
Q1 | $1.93M | Sell |
71,025
-1,423
| -2% | -$39.8K | 0.01% | 967 |
|
|
2023
Q4 | $2.25M | Buy |
72,448
+3,530
| +5% | +$91.5K | 0.02% | 906 |
|
|
2023
Q3 | $1.74M | Hold |
68,918
| – | – | 0.01% | 964 |
|
|
2023
Q2 | $1.45M | Sell |
68,918
-1,921
| -3% | -$36.4K | 0.01% | 1070 |
|
|
2023
Q1 | $1.21M | Hold |
70,839
| – | – | 0.01% | 1130 |
|
|
2022
Q4 | $1.42M | Buy |
70,839
+7,955
| +13% | +$154K | 0.01% | 1038 |
|
|
2022
Q3 | $1.35M | Hold |
62,884
| – | – | 0.01% | 1043 |
|
|
2022
Q2 | $1.24M | Hold |
62,884
| – | – | 0.01% | 1103 |
|
|
2022
Q1 | $1.48M | Buy |
62,884
+22,831
| +57% | +$530K | 0.01% | 1121 |
|
|
2021
Q4 | $1.09M | Hold |
40,053
| – | – | 0.01% | 1091 |
|
|
2021
Q3 | $1.1M | Buy |
40,053
+1,626
| +4% | +$42.7K | 0.01% | 1073 |
|
|
2021
Q2 | $1.09M | Hold |
38,427
| – | – | 0.01% | 1113 |
|
|
2021
Q1 | $1.31M | Sell |
38,427
-3,396
| -8% | -$130K | 0.01% | 1013 |
|
|
2020
Q4 | $1.39M | Sell |
41,823
-2,973
| -7% | -$109K | 0.01% | 985 |
|
|
2020
Q3 | $1.44M | Hold |
44,796
| – | – | 0.02% | 866 |
|
|
2020
Q2 | $1.23M | Buy |
44,796
+5,212
| +13% | +$124K | 0.01% | 944 |
|
|
2020
Q1 | $635K | Hold |
39,584
| – | – | 0.01% | 1087 |
|
|
2019
Q4 | $945K | Hold |
39,584
| – | – | 0.01% | 1126 |
|
|
2019
Q3 | $698K | Buy |
39,584
+2,568
| +7% | +$49.6K | 0.01% | 1242 |
|
|
2019
Q2 | $948K | Buy |
37,016
+3,783
| +11% | +$105K | 0.01% | 1131 |
|
|
2019
Q1 | $966K | Hold |
33,233
| – | – | 0.01% | 1099 |
|
|
2018
Q4 | $436K | Hold |
33,233
| – | – | 0.01% | 1450 |
|
|
2018
Q3 | $672K | Sell |
33,233
-4,419
| -12% | -$99.8K | 0.01% | 1345 |
|
|
2018
Q2 | $890K | Buy |
37,652
+4,160
| +12% | +$107K | 0.01% | 1068 |
|
|
2018
Q1 | $754K | Hold |
33,492
| – | – | 0.01% | 1138 |
|
|
2017
Q4 | $1.04M | Buy |
+33,492
| New | +$989K | 0.01% | 1015 |
|
Other funds holding INSM
BBA
DGM
OAG
MetLife Investment Management's INSM Position: Q2 2026 in Review
MetLife Investment Management reduced its Insmed (INSM) stake by 3% in Q2 2026, selling an estimated $44.1K and leaving 11,926 shares worth $1.27M. The position accounts for 0.01% of the portfolio, ranked #1399.
MetLife Investment Management first reported a position in INSM in Q4 2017 and has held it in 35 quarters since. The position peaked at $7.65M in Q1 2025. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.
- MetLife Investment Management held 11,926 shares of Insmed worth $1.27M as of Q2 2026.
- MetLife Investment Management sold 364 Insmed shares in Q2 2026, an estimated $44.1K.
- Insmed made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1399 holding.
- MetLife Investment Management first reported a position in Insmed in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's Insmed position peaked at $7.65M in Q1 2025.
- 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.